Stop Reading the PR, Start Reading the Capital Flow 📈

As founders, we know that what a team says in a roadmap often differs from what’s happening in the codebase. The public markets are no different. While retail sentiment is currently being crushed by macro volatility, a granular PHR insider trading analysis reveals a massive "conviction signal" that the headlines are completely ignoring.

Earlier this week, as Phreesia ($PHR) tested its 52-week lows, its largest shareholder, Pale Fire Capital, didn't just hold—they scaled. They deployed $18.3 million to absorb 1.6 million shares in just three days, effectively increasing their stake to 12.7%.

In the startup world, we call this "doubling down on product-market fit." In the public markets, it’s a high-stakes bet that the current SaaS sell-off has decoupled from the actual unit economics of the business. When an insider with a "builder" mindset writes a check that large during a market panic, they aren't speculating; they are calling a fundamental bottom.

Are we looking at a classic "valuation reset" for medical tech, or is this the ultimate asymmetric bet of 2026? I’m leaning toward the latter. Follow the money, because the money has no ego.

What’s your take? Are you pivoting to defensive plays or following the insider accumulation?